Skip to main content

Table 3 Risk factors and co-morbid conditions at baseline

From: Diabetes treatment patterns and goal achievement in primary diabetes care (DiaRegis) - study protocol and patient characteristics at baseline

 

Total (n = 3,810)

Men (n = 2,033)

Women (n = 1,777)

OR (95%CI)

p-value

Smoker

11.9

14.4

9.1

1.69 (1.37-2.08)

< 0.0001

Any alcohol, even rare

62.9

79.9

43.6

5.15 (4.38-6.06)

< 0.0001

Any Sports, even rare

40.1

45.0

34.6

1.55 (1.35-1.78)

< 0.0001

Dyslipidemia

63.3

64.7

61.6

1.14 (1.00-1.31)

< 0.05

Hypertension

84.4

83.6

85.3

0.88 (0.74-1.05)

n.s.

Malignancy

2.0

1.8

2.2

0.83 (0.52-1.30)

n.s.

Coronary artery disease

17.9

23.4

11.7

2.31 (1.93-2.76)

< 0.0001

   Prior MI

34.4

38.9

24.1

2.00 (1.38-2.92)

< 0.001

Prior stroke/TIA

4.6

5.0

4.2

1.18 (0.87-1.60)

n.s.

PAD

6.0

7.7

4.1

1.95 (1.46-2.60)

< 0.0001

Amputation*

0.9

1.2

0.6

2.20 (1.05-4.60)

< 0.05

Heart failure

9.9

10.4

9.3

1.13 (0.91-1.40)

n.s.

Autonomous neuropathy

3.4

3.7

2.9

1.28 (0.89-1.84)

n.s.

Symptoms of peripheral neuropathy

14.4

15.7

12.8

1.27 (1.06-1.53)

< 0.05

NPDR

3.8

3.6

3.9

0.91 (0.65-1.28)

n.s.

PDR

0.5

0.5

0.5

0.97 (0.39-2.40)

n.s.

Blindness

0.2

0.2

0.2

1.17 (0.26-5.22)

n.s.

Clinically relevant depression

5.4

3.6

7.4

0.47 (0.35-0.63)

< 0.0001

  1. PDR, proliferative diabetic retinopathy; MI, Myocardial Infarction; NPDR, non-proliferative diabetic retinopathy; PAD, peripheral arterial disease; TIA, transitory ischemic attack; OR, odds ratio; CI, confidence interval; * toe, foot or lower extremity